Medium-chain fatty acid reduces lipid accumulation by regulating expression of lipid-sensing genes in human liver cells with steatosis

International Journal of Food Sciences and Nutrition

Volumn 67, Issue 3, 2016, Pages 288-297

  Wang, Baogui ^a   Fu, Jing ^a   Li, Lumin ^a   Gong, Deming ^b   Wen, Xuefang ^a   Yu, Ping ^a   Zeng, Zheling ^a  

^a NANCHANG UNIVERSITY   (China)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Lipolysis; Liver X receptor ; Medium chain fatty acid; Non alcoholic fatty liver disease; Sterol regulatory element binding protein 1

Indexed keywords

FATTY ACID; MESSENGER RNA;

APOPTOSIS; CELL LINE; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; FATTY LIVER; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LIPID METABOLISM; LIVER CELL; METABOLISM; PHYSIOLOGY;

APOPTOSIS; CELL LINE; CELL SURVIVAL; FATTY ACIDS; FATTY LIVER; GENE EXPRESSION REGULATION; HEPATOCYTES; HUMANS; LIPID METABOLISM; RNA, MESSENGER;

EID: 84978318072     PISSN: 09637486     EISSN: 14653478     Source Type: Journal    
DOI: 10.3109/09637486.2016.1153611     Document Type: Article

References (52)

1. Akpa MM, Point F, Sawadogo S, Radenne A, Mounier C. 2010. Inhibition of insulin and T3-induced fatty acid synthase by hexanoate. Lipids 45: 997-1009.
2. Al Rifai M, Silverman MG, Nasir K, Budoff MJ, Blankstein R, Szklo M, Katz R, Blumenthal RS, Blaha MJ. 2015. The association of nonalcoholic fatty liver disease, obesity, and metabolic syndrome, with systemic inflammation and subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis 239: 629-633.
3. Anstee QM, Goldin RD. 2006. Mouse models in non-alcoholic fatty liver disease and steatohepatitis research. Int J Exp Pathol. 87: 1-16.
4. Aoyama T, Nosaka N, Kasai M. 2007. Research on the nutritional characteristics of medium-chain fatty acids. J Med Invest. 54: 385-388.
5. Araya J, Rodrigo R, Videla LA, Thielemann L, Orellana M, Pettinelli P, Poniachik J. 2004. Increase in long-chain polyunsaturated fatty acid n-6/n- 3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease. Clin Sci (Lond). 106: 635-643.
6. Babayan VK. 1987. Medium chain triglycerides and structured lipids. Lipids 22: 417-420.
7. Bach AC, Babayan VK. 1982. Medium-chain triglycerides: an update. Am J Clin Nutr. 36: 950-962.
8. Christensen E, Hagve TA, Grønn M, Christophersen BO. 1989. Beta-oxidation of medium chain (C8-C14) fatty acids studied in isolated liver cells. Biochim Biophys Acta. 1004: 187-195.
9. Clouston AD, Jonsson JR, Powell EE. 2007. Steatosis as a cofactor in other liver diseases: hepatitis C virus, alcohol, hemochromatosis, and others. Clin Liver Dis. 11: 173-189.
10. Day CP. 2002. Pathogenesis of steatohepatitis. Best Pract Res Clin Gastroenterol. 16: 663-678.
11. Deng QG, She H, Cheng JH, French SW, Koop DR, Xiong S, Tsukamoto H. 2005. Steatohepatitis induced by intragastric overfeeding in mice. Hepatology. 42: 905-914.
12. de Sousa Abreu R, Penalva LO, Marcotte EM, Vogel C. 2009. Global signatures of protein and mRNA expression levels. Mol Biosyst. 5: 1512-1526.
13. Ferreira L, Lisenko K, Barros B, Zangeronimo M, Pereira L, Sousa R. 2014. Influence of medium-chain triglycerides on consumption and weight gain in rats: a systematic review. J Anim Physiol Anim Nutr (Berl). 98: 1-8.
14. Fu J, Wang B, Gong D, Zeng C, Jiang Y, Zeng Z. 2015. Camphor tree seed kernel oil reduces body fat deposition and improves blood lipids in rats. J Food Sci. 80: 1912-1917.
15. Gómez-Lechón MJ, Donato MT, Martínez-Romero A, Jiménez N, Castell JV, OConnor JE. 2007. A human hepatocellular in vitro model to investigate steatosis. Chem Biol Interact. 165: 106-116.
16. Guo W, Lei T, Wang T, Corkey BE, Han J. 2003. Octanoate inhibits triglyceride synthesis in 3T3-L1 and human adipocytes. J Nutr. 133: 2512-2518.
17. Gura T. 2003. Obesity drug pipeline not so fat. Science. 299: 849.
18. Haemmerle G, Zimmermann R, Zechner R. 2003. Letting lipids go: hormone-sensitive lipase. Curr Opin Lipidol. 14: 289-297.
19. Han J, Hamilton JA, Kirkland JL, Corkey BE, Guo W. 2003. Medium-chain oil reduces fat mass and down-regulates expression of adipogenic genes in rats. Obes Res. 11: 734-744.
20. Hardy S, Langelier Y, Prentki M. 2000. Oleate activates phosphatidylinositol 3-kinase and promotes proliferation and reduces apoptosis of MDA-MB-231 breast cancer cells, whereas palmitate has opposite effects. Cancer Res. 60: 6353-6358.
21. Kasai M, Nosaka N, Maki H, Negishi S, Aoyama T, Nakamura M, Suzuki Y, Tsuji H, Uto H, Okazaki M. 2003. Effect of dietary medium- and long-chain triacylglycerols (MLCT) on accumulation of body fat in healthy humans. Asia Pac J Clin Nutr. 12: 151-160.
22. Kelner K, Helmuth L. 2003. Obesity-what is to be done? Science. 299: 845.
23. Koteish A, Diehl AM. 2001. Obesity and liver disease. Curr Treat Options Gastroenterol. 4: 101-105.
24. Lehr L, Canola K, Léger B, Giacobino JP. 2009. Differentiation and characterization in primary culture of white adipose tissue brown adipocyte-like cells. Int J Obes (Lond). 33: 680-686.
25. Li Q, Zhong W, Qiu YP, Kang XQ, Sun XH, Tan XB, Zhao YT, Sun XG, Jia W, Zhou ZX. 2013. Preservation of hepatocyte nuclear factor-4α contributes to the beneficial effect of dietary medium chain triglyceride on alcohol-induced hepatic lipid dyshomeostasis in rats. Alcohol Clin Exp Res. 37: 587-598.
26. Listenberger LL, Han X, Lewis SE, Cases S, Farese RV, Ory DS, Schaffer JE. 2003. Triglyceride accumulation protects against fatty acid-induced lipotoxicity. Proc Natl Acad Sci USA. 100: 3077-3082.
27. Liu YH, Xue CY, Zhang Y, Xu Q, Yu XM, Zhang XS, Wang J, Zhang RX, Gong X, Guo CJ. 2011. Triglyceride with medium-chain fatty acids increases the activity and expression of hormone-sensitive lipase in white adipose tissue of C57BL/6J mice. Biosci Biotechnol Biochem. 75: 1939-1944.
28. Liu YH, Zhang Y, Xu Q, Yu XM, Zhang XS, Wang J, Xue C, Yang XY, Zhang RX, Xue CY. 2012. Increased norepinephrine by medium-chain triglyceride attributable to lipolysis in white and brown adipose tissue of C57BL/6J mice. Biosci Biotechnol Biochem. 76: 1213-1218.
29. Ludwig J, Viggiano TR, McGill DB, Oh BJ. 1980. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc. 55: 434-438.
30. Matsuo T, Matsuo M, Kasai M, Takeuchi H. 2001. Effects of a liquid diet supplement containing structured medium- and long-chain triacylglycerols on bodyfat accumulation in healthy young subjects. Asia Pac J Clin Nutr. 10: 46-50.
31. Matsuo T, Takeuchi H. 2004. Effects of structured medium- and long-chain triacylglycerols in diets with various levels of fat on body fat accumulation in rats. Br J Nutr. 91: 219-225.
32. Memon RA, Feingold KR, Moser AH, Fuller J, Grunfeld C. 1998. Regulation of fatty acid transport protein and fatty acid translocase mRNA levels by endotoxin and cytokines. Am J Physiol. 274: 210-217.
33. Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. 1999. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology. 116: 1413-1419.
34. Nakakuki M, Kawano H, Notsu T, Imada K, Mizuguchi K, Shimano H. 2014. A novel processing system of sterol regulatory element-binding protein-1c regulated by polyunsaturated fatty acid. J Biochem. 155: 301-313.
35. Ochiai M, Matsuo T. 2012. Increased stearoyl-CoA desaturase index and triglyceride content in the liver of rats after a single bout of swimming exercise. Biosci Biotechnol Biochem. 76: 1350-1355.
36. Pagano G, Pacini G, Musso G, Gambino R, Mecca F, Depetris N, Cassader M, David E, Cavallo P, Rizzetto M. 2002. Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association. Hepatology. 35: 367-372.
37. Papamandjaris AA, MacDougall DE, Jones PJ. 1998. Medium chain fatty acid metabolism and energy expenditure: obesity treatment implications. Life Sci. 62: 1203-1215.
38. Powell EE, Jonsson JR, Clouston AD. 2005. Steatosis: co-factor in other liver diseases. Hepatology. 42: 5-13.
39. Repa JJ, Liang G, Ou J, Bashmakov Y, Lobaccaro JM, Shimomura I, Shan B, Brown MS, Goldstein JL, Mangelsdorf DJ. 2000. Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta. Genes Dev. 14: 2819-2830.
40. Roncero C, Goodridge AG. 1992. Hexanoate and octanoate inhibit transcription of the malic enzyme and fatty acid synthase genes in chick embryo hepatocytes in culture. J Biol Chem. 267: 14918-14927.
41. Sato K, Cho Y, Tachibana S, Chiba T, Schneider WJ, Akiba Y. 2005. Impairment of VLDL secretion by medium-chain fatty acids in chicken primary hepatocytes is affected by the chain length. J Nutr. 135: 1636-1641.
42. Shinohara H, Ogawa A, Kasai M, Aoyama T. 2005. Effect of randomly interesterified triacylglycerols containing medium- and long-chain fatty acids on energy expenditure and hepatic fatty acid metabolism in rats. Biosci Biotechnol Biochem. 69: 1811-1818.
43. Shinohara H, Wu J, Kasai M, Aoyama T. 2006. Randomly interesterified triacylglycerol containing medium- and long-chain fatty acids stimulates fatty acid metabolism in white adipose tissue of rats. Biosci Biotechnol Biochem. 70: 2919-2926.
44. Tachibana S, Sato K, Takahashi T, Akiba Y. 2002. Octanoate inhibits very low-density lipoprotein secretion in primary cultures of chicken hepatocytes. Comp Biochem Physiol A Mol Integr Physiol. 132: 621-627.
45. Throsby K. 2009. The war on obesity as a moral project: weight loss drugs, obesity surgery and negotiating failure. Sci Cult. 18: 201-216.
46. Tsochatzis EA, Manolakopoulos S, Papatheodoridis GV, Archimandritis AJ. 2009. Insulin resistance and metabolic syndrome in chronic liver diseases: old entities with new implications. Scand J Gastroenterol. 44: 6-14.
47. Tsuji H, Kasai M, Takeuchi H, Nakamura M, Okazaki M, Kondo K. 2001. Dietary medium-chain triacylglycerols suppress accumulation of body fat in a double-blind, controlled trial in healthy men and women. J Nutr. 131: 2853-2859.
48. Wang D, Wei Y, Pagliassotti MJ. 2006. Saturated fatty acids promote endoplasmic reticulum stress and liver injury in rats with hepatic steatosis. Endocrinology. 147: 943-951.
49. Wei Y, Wang D, Topczewski F, Pagliassotti MJ. 2006. Saturated fatty acids induce endoplasmic reticulum stress and apoptosis independently of ceramide in liver cells. Am J Physiol Endocrinol Metab. 291: 275-281.
50. Wood AJ, Knopp RH. 1999. Drug treatment of lipid disorders. N Engl J Med. 341: 498-511.
51. Xue C, Liu Y, Wang J, Zhang R, Zhang Y, Zhang J, Zheng Z, Yu X, Jing H, Nosaka N. 2009. Consumption of medium- and long-chain triacylglycerols decreases body fat and blood triglyceride in Chinese hypertriglyceridemic subjects. Eur J Clin Nutr. 63: 879-886.
52. Zhou J, Febbraio M, Wada T, Zhai Y, Kuruba R, He J, Lee JH, Khadem S, Ren S, Li S. 2008. Hepatic fatty acid transporter Cd36 is a common target of LXR, PXR, and PPARgamma in promoting steatosis. Gastroenterology. 134: 556-567.